CARY, N.C.--(BUSINESS WIRE)--Focal Medical, Inc., a privately held, biopharmaceutical company developing novel precision therapeutic products today announced successful completion of the nonclinical ...
ACT-IOP-003 is an implantable iontophoretic product designed to safely achieve high concentration of gemcitabine in the pancreas, via non-circulatory pathways and with little to no systemic drug ...
A new study published in the American Journal of Physiology—Heart and Circulatory Physiology reveals that chronic kidney disease (CKD) accelerates cognitive decline through interconnected damage to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback